Sunshine Insurance Group and existing backer Tencent both took part in a series D round that took the medical management software provider's total funding past $115m.

In the second half of out 2020 roundup we look at growth areas including digital health and health insurance, online education platforms and financial technology.

Tencent co-led a series E1 round for the cancer drug development services provider, which counts China Electronics Corporation and Ping An as earlier investors.

Amgen has participated in an $8.4m round for the antibody therapeutics developer, which aims to tackle chronic kidney disease.

Based on inventions from Harvard and Dana-Farber Cancer Institute, Neomorph was launched earlier this year with the support of Deerfield Management.

The Saudi Aramco and Schlumberger-backed chemical analysis device makers shares have nearly tripled in price since it went public on Friday.

Alexandria Venture Investments was among the participants in the neurological disease drug developer's series B round.

Xiamen C&D Emerging Industry Equity Investment was among the investors in a $91.8m round that will support the antibody producer's research and development.

The medical data provider has now secured almost $78m in total, with Novartis and Qualcomm venture DRx Capital returning for its series B round.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.